New diabetes clinical trial: GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

Published on: March 28, 2024 at 11:00PM
Conditions: Type 1 Diabetes
Interventions: Drug: Placebo; Drug: Semaglutide (Rybelsus®)
Sponsors: Vanderbilt University Medical Center
Recruiting
https://ift.tt/8obLrvk